NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
NIH's New Innovator Award funds highly creative, early-career researchers with innovative projects impacting NIH's mission, encouraging diverse applicants across all research areas.
Funder: [National Institutes of Health (NIH) - https://www.nih.gov]
Due Dates: August 18, 2023 (New applications) | August 18, 2023 (AIDS applications)
Funding Amounts: Up to $900,000 in direct costs for first 3 years; up to $600,000 for subsequent 2 years; total project period 5 years.
Summary: Supports exceptionally creative early stage investigators proposing highly innovative research with potential for broad impact across NIH mission areas.
Key Information: Applications must be new (no resubmissions); clinical trial optional; strong emphasis on innovation and investigator creativity; diverse applicants encouraged.
Description
The NIH Director’s New Innovator Award Program is designed to support early stage investigators (ESIs) who demonstrate exceptional creativity and propose highly innovative research projects with the potential for unusually broad and significant impact on biomedical, behavioral, or social sciences relevant to the NIH mission. Unlike traditional NIH grants, this award does not require extensive preliminary data and emphasizes the innovativeness of the research and the creativity of the investigator.
This program is part of the NIH Common Fund’s High-Risk, High-Reward Research Program and complements other NIH efforts to support ESIs, such as R01 grants. The award provides substantial flexibility for investigators to pivot their research direction to maximize impact.
Applications are encouraged from individuals of diverse backgrounds and from a wide range of eligible institutions, including minority-serving and less research-intensive institutions, across all geographic locations in the U.S. Research topics may span behavioral, social, biomedical, applied, and formal sciences, and may involve basic, translational, or clinical research.
The award is for a total of five years, issued in two segments: a three-year initial award (up to $900,000 direct costs) followed by a two-year award (up to $600,000 direct costs), contingent on progress. Applicants must commit at least 25% effort (three person-months) annually to the project.
